BEAM vs. NTLA
Compare and contrast key facts about Beam Therapeutics Inc. (BEAM) and Intellia Therapeutics, Inc. (NTLA).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BEAM or NTLA.
Performance
BEAM vs. NTLA - Performance Comparison
Returns By Period
In the year-to-date period, BEAM achieves a -11.65% return, which is significantly higher than NTLA's -54.03% return.
BEAM
-11.65%
1.69%
-2.32%
-12.45%
N/A
N/A
NTLA
-54.03%
-33.52%
-45.87%
-50.16%
-1.31%
N/A
Fundamentals
| BEAM | NTLA | |
|---|---|---|
| Market Cap | $2.31B | $1.70B |
| EPS | -$1.58 | -$5.45 |
| Total Revenue (TTM) | $349.64M | $43.09M |
| Gross Profit (TTM) | $327.80M | $35.51M |
| EBITDA (TTM) | -$166.30M | -$521.07M |
Key characteristics
| BEAM | NTLA | |
|---|---|---|
| Sharpe Ratio | -0.06 | -0.74 |
| Sortino Ratio | 0.50 | -0.93 |
| Omega Ratio | 1.05 | 0.89 |
| Calmar Ratio | -0.05 | -0.50 |
| Martin Ratio | -0.12 | -1.62 |
| Ulcer Index | 36.82% | 28.40% |
| Daily Std Dev | 74.47% | 61.58% |
| Max Drawdown | -86.76% | -92.10% |
| Current Drawdown | -82.00% | -92.07% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Correlation
The correlation between BEAM and NTLA is 0.71, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Risk-Adjusted Performance
BEAM vs. NTLA - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Beam Therapeutics Inc. (BEAM) and Intellia Therapeutics, Inc. (NTLA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
BEAM vs. NTLA - Dividend Comparison
Neither BEAM nor NTLA has paid dividends to shareholders.
Drawdowns
BEAM vs. NTLA - Drawdown Comparison
The maximum BEAM drawdown since its inception was -86.76%, smaller than the maximum NTLA drawdown of -92.10%. Use the drawdown chart below to compare losses from any high point for BEAM and NTLA. For additional features, visit the drawdowns tool.
Volatility
BEAM vs. NTLA - Volatility Comparison
The current volatility for Beam Therapeutics Inc. (BEAM) is 24.02%, while Intellia Therapeutics, Inc. (NTLA) has a volatility of 29.12%. This indicates that BEAM experiences smaller price fluctuations and is considered to be less risky than NTLA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
BEAM vs. NTLA - Financials Comparison
This section allows you to compare key financial metrics between Beam Therapeutics Inc. and Intellia Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities